R&D Partner Content 5th iPSC Drug Development Summit Advance iPSC therapies from bench to bedside with 30+ industry experts at this year’s summit.
R&D Partner Content Register Now for AAPS PharmSci 360! Learn from pharmaceutical scientists involved at every stage of the drug development pipeline at PharmSci 360.
R&D Partner Content Injectable Drug Delivery 2025 – Driving Innovation Through C... Press Release: Injectable Drug Delivery 2025 – Driving Innovation Through Collaboration LONDON, UK – 24–25 June 2025
R&D Partner Content 4th In Vivo Cell Engineering & Gene Editing Summit This forum brings together the brightest minds from biopharma, academia, and regulatory leadership to explore the full translational journey
R&D Partner Content 13th Tumor Models Summit Boston | July 22-23, 2025 | Boston,... Improve preclinical tumor models to enhance translational oncology success.
R&D Partner Content 6th RNA Editing Summit | July 29-31, 2025 | Advance RNA Edit... The 6th RNA Editing Summit returns to Boston this July, bringing together 60+ experts to propel the next generation of RNA editing therapies
News EU clears first drug therapy for rare disease cALD Neuraxpharm and Minoryx' Nezglyal has become the first approved drug therapy in the EU for rare neurodegenerative disease cALD.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
